Unlock AI-driven, actionable R&D insights for your next breakthrough.

Polyglycolic Acid Tube: Comprehensive Analysis Of Structural Properties, Manufacturing Processes, And Biomedical Applications

MAR 25, 202657 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Polyglycolic acid tube represents a critical biodegradable polymer construct extensively utilized in tissue engineering, surgical implants, and petroleum downhole applications. As the simplest aliphatic polyester, polyglycolic acid (PGA) exhibits exceptional mechanical strength, gas barrier properties, and complete biodegradability through hydrolytic degradation into non-toxic glycolic acid metabolites 3. This article provides an in-depth technical analysis of polyglycolic acid tube fabrication methodologies, structural optimization strategies, performance characteristics under physiological and industrial conditions, and emerging applications across medical and energy sectors.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Composition And Structural Characteristics Of Polyglycolic Acid Tube

Polyglycolic acid tube is constructed from polyglycolide, a linear aliphatic polyester synthesized primarily through ring-opening polymerization of glycolide monomers 1. The polymer chain consists of repeating glycolic acid ester linkages (-OCH₂CO-), forming a highly crystalline structure with a melting point ranging from 215°C to 225°C for homopolymers 1. The crystallinity of PGA typically exceeds 45-55%, contributing to its superior mechanical properties and dimensional stability 2.

The molecular architecture of PGA tubes can be tailored through copolymerization strategies. Incorporation of lactide, ε-caprolactone, or trimethylene carbonate as comonomers enables modulation of degradation kinetics and mechanical flexibility 3. For tissue engineering scaffolds, poly(lactide-co-glycolide) (PLGA) copolymers with PGA:PLA ratios of 85:15 to 99:1 are commonly employed to balance structural integrity with controlled degradation rates 3. The weight-average molecular weight (Mw) of PGA suitable for tube fabrication typically ranges from 50,000 to 200,000 Da, with polydispersity indices (Mw/Mn) between 1.5 and 3.0 19.

Melt viscosity constitutes a critical processing parameter for PGA tube extrusion. High-quality tubes require PGA resins exhibiting melt viscosities of 200-2,000 Pa·s at 270°C and shear rates of 120 sec⁻¹ 413. Lower viscosity grades (20-500 Pa·s at melting point +20°C, 100 sec⁻¹ shear rate) are preferred for compression molding and solution casting applications 7. The residual glycolide monomer content must be maintained below 0.5 wt% to achieve optimal tensile strength exceeding 750 MPa and knot strength above 600 MPa in filament-based tube constructs 11.

Manufacturing Processes For Polyglycolic Acid Tube Fabrication

Extrusion-Based Tube Formation

Solidification and extrusion molding represents the predominant industrial method for producing PGA tubes with diameters exceeding 100 mm 413. The process involves melting PGA resin at 240-280°C, extruding through annular dies, and applying controlled back pressure during solidification to suppress radial expansion 1320. Critical process parameters include:

  • Extrusion temperature: 250-270°C to maintain melt viscosity within 200-2,000 Pa·s range 4
  • Die temperature: 220-240°C to prevent premature crystallization 13
  • Take-off speed: 0.5-5 m/min with synchronized back pressure application 20
  • Cooling rate: Rapid quenching in liquid baths at ≤10°C to minimize spherulite size and enhance transparency 11

The resulting extruded tubes exhibit densities of 1.575-1.625 g/cm³ and can be manufactured with wall thicknesses from 5 mm to 100 mm 20. For larger diameter tubes (100-500 mm) intended for petroleum ball sealer applications, post-extrusion compression and controlled drawing are essential to reduce residual stress and improve machinability 13.

Tubular Scaffold Construction Via Felting Techniques

For biomedical tissue engineering applications, tubular PGA constructs are fabricated by wrapping non-woven PGA fiber sheets around gas-permeable silicone mandrels 2. The manufacturing sequence comprises:

  1. Fiber sheet preparation: Melt-spinning PGA resin (residual monomer <0.5 wt%) followed by quenching in liquid baths at ≤10°C 11
  2. Mandrel wrapping: Overlapping fiber sheets to create tubular geometry with controlled wall thickness (0.8-1.5 mm) 2
  3. Seam formation: Entangling pulled fibers across the interface using felting needles to achieve seam densities of 45-75 mg/cc 2
  4. Chemical treatment: Sequential washing with non-polar solvents and primary alcohols (ethanol) to remove heavy metal contaminants 2
  5. Surface modification: Treatment with 1M NaOH to increase degradation rate and wettability while maintaining seam integrity 2

This approach produces tubular scaffolds with uniform PGA density throughout the construct, critical for consistent cell seeding and tissue ingrowth in vascular grafts and tracheal replacements 2.

Multilayer Co-Extrusion For Enhanced Barrier Properties

Advanced PGA tube designs incorporate multilayer structures combining PGA barrier layers with thermoplastic polyester (PET) or other resins to optimize gas impermeability and mechanical durability 16. Co-injection stretch blow molding enables fabrication of containers where PGA intermediate layers (10-30 μm thickness) are embedded between inner and outer PET layers 16. The process involves:

  • Preform co-injection: Simultaneous injection of PGA and PET melts into segmented mold cavities at 260-280°C 16
  • Biaxial stretch blow molding: Radial and axial stretching at 90-110°C to induce molecular orientation 16
  • Heat treatment: Crystallization of PET layers at 180-200°C while maintaining PGA layer integrity 16

These multilayer tubes demonstrate oxygen transmission rates below 0.05 cc/(m²·day·atm) and withstand hot-filling at 93°C for 20 seconds without delamination 16.

Mechanical Properties And Performance Characteristics Of Polyglycolic Acid Tube

Tensile Strength And Modulus

High-molecular-weight PGA tubes exhibit exceptional mechanical performance. Monofilament tubes produced via optimized melt-spinning and stretching protocols achieve:

  • Tensile strength: 750-900 MPa (measured per ASTM D638) 11
  • Knot strength: 600-750 MPa, critical for surgical suture applications 11
  • Elastic modulus: 6,000-8,000 MPa at 23°C, increasing to >10,000 MPa with inorganic filler incorporation 19
  • Elongation at break: 15-25% for homopolymers, 30-50% for PLGA copolymers 3

The tensile modulus of PGA composites can be enhanced through addition of calcium-containing inorganic compounds (calcium carbonate, hydroxide, or phosphate) at 5-20 wt%, achieving moduli exceeding 5,800 MPa while maintaining thermal stability 1519. However, excessive filler loading (>25 wt%) may accelerate hydrolytic degradation and reduce ductility 19.

Thermal Stability And Processing Window

PGA tubes demonstrate thermal stability up to 200°C under inert atmospheres, with onset of thermal degradation occurring at 220-240°C 1. Key thermal properties include:

  • Melting point (Tm): 215-225°C for homopolymers, 180-210°C for PLGA copolymers 13
  • Glass transition temperature (Tg): 35-45°C, limiting low-temperature flexibility 18
  • Crystallization temperature (Tc): 170-190°C during cooling from melt 18
  • Heat deflection temperature (HDT): 150-170°C at 0.45 MPa load 19

Melt stability during processing is enhanced by incorporating carboxyl end-blocking agents (e.g., epoxy compounds at 0.1-1.0 wt%) and heat stabilizers (hindered phenols, phosphites) to suppress chain scission and discoloration 15. Optimized formulations maintain yellowness index below 5 and weight-average molecular weight retention >90% after multiple extrusion cycles 5.

Hydrolytic Degradation Kinetics

PGA tubes undergo bulk erosion through random hydrolytic cleavage of ester bonds, with degradation rates dependent on:

  • Molecular weight: Higher Mw polymers (>100,000 Da) exhibit slower initial degradation 3
  • Crystallinity: Amorphous regions degrade preferentially, with crystalline domains persisting longer 18
  • pH environment: Acidic (pH 4-6) and alkaline (pH 8-10) conditions accelerate hydrolysis compared to neutral pH 2
  • Temperature: Degradation rate doubles approximately every 10°C increase from 25°C to 60°C 12

In physiological conditions (37°C, pH 7.4), PGA homopolymer tubes lose 50% of initial tensile strength within 2-4 weeks and achieve complete mass loss in 4-6 months 38. PLGA copolymers with higher lactide content (e.g., 85:15 PGA:PLA) extend degradation timelines to 6-12 months, suitable for long-term tissue scaffolds 3. Surface treatment with 1M NaOH increases degradation rate by 30-50% through enhanced water penetration 2.

Applications Of Polyglycolic Acid Tube In Biomedical Engineering

Tissue-Engineered Vascular Grafts

Tubular PGA scaffolds serve as foundational constructs for growing decellularized extracellular matrix (ECM) vascular grafts 2. The fabrication process involves:

  1. Scaffold preparation: Felted PGA tubes (inner diameter 4-8 mm, wall thickness 1.0-1.5 mm, seam density 50-70 mg/cc) mounted on silicone mandrels 2
  2. Cell seeding: Inoculation with vascular smooth muscle cells or fibroblasts at densities of 5×10⁶ to 2×10⁷ cells/cm² 2
  3. Bioreactor culture: Perfusion culture under pulsatile flow (1-5 mL/min) for 8-12 weeks to promote ECM deposition 2
  4. Decellularization: Treatment with detergents (SDS, Triton X-100) to remove cellular components while preserving ECM architecture 2
  5. Terminal sterilization: Ethylene oxide exposure at 70-90°F and 5-15 psig for ≥4 hours 10

The resulting tissue-engineered vascular grafts (TEVGs) demonstrate burst pressures exceeding 2,000 mmHg, suture retention strengths >200 g, and patency rates >80% in preclinical large animal models over 6-month implantation periods 2. Attachment of non-biodegradable polyethylene terephthalate (PET) supports at tube ends facilitates surgical anastomosis and prevents end-fraying during handling 2.

Surgical Sutures And Wound Closure Devices

PGA monofilament and braided tubes constitute the gold standard for absorbable surgical sutures since their introduction in the 1970s 89. Key performance specifications include:

  • United States Pharmacopeia (USP) size range: 10-0 to 2 (diameters 0.02-0.5 mm) 9
  • Tensile strength retention: >70% at 14 days, <30% at 21 days post-implantation 12
  • Absorption timeline: Complete mass loss within 90-120 days 8
  • Tissue reactivity: Minimal inflammatory response (Grade 1-2 per ISO 10993-6) 8

PGA sutures are colored green using 0.03-0.5 wt% 1,4-bis(p-toluidino)-anthraquinone (D&C Green No. 6) to enhance visibility against tissue and blood 14. Storage stability is ensured through packaging in air-tight, water vapor-impermeable laminate films (aluminum foil/polyethylene) with internal atmospheres containing <0.05 wt% moisture and inert gases (nitrogen, argon) 12. Under these conditions, sutures maintain >90% of initial tensile strength for ≥12 months at 22°C storage 12.

Orthopedic Fixation Devices

Solid PGA tubes are machined into biodegradable orthopedic implants including:

  • Interference screws: Diameters 6-12 mm, lengths 20-40 mm for anterior cruciate ligament (ACL) reconstruction 8
  • Bone pins: Diameters 1.5-4.0 mm, lengths 15-50 mm for fracture fixation 8
  • Meniscal repair darts: Barbed designs with shaft diameters 2-3 mm 8

These devices provide initial fixation strengths of 200-400 N (shear) and 150-300 N (pull-out), sufficient for early-stage healing 8. Degradation proceeds over 6-12 months, with gradual load transfer to regenerating bone tissue 8. Incorporation of calcium phosphate fillers (10-30 wt%) enhances osteoconductivity and buffers acidic degradation products 15.

Drug Delivery Systems

Tubular PGA constructs enable controlled release of therapeutic agents through:

  • Matrix diffusion: Drugs dispersed within PGA tube walls diffuse outward as polymer hydrates 5
  • Erosion-controlled release: Drug release rate coupled to polymer degradation kinetics 3
  • Reservoir systems: Hollow PGA tubes containing drug cores with rate-controlling membranes 5

For example, PGA tubes loaded with bone morphogenetic protein-2 (BMP-2) at 0.5-2.0 mg/mL demonstrate sustained release over 4-8 weeks, promoting ectopic bone formation in rat models 8. Similarly, antibiotic-loaded PGA tubes (gentamicin 5-10 wt%) provide local infection prophylaxis in contaminated surgical sites 8.

Applications Of Polyglycolic Acid Tube In Petroleum Engineering

Downhole Ball Sealers For Hydraulic Fracturing

PGA tubes with diameters of 100-500 mm are machined into ball sealers for temporary zonal isolation during multi-stage hydraulic fracturing operations 413. Manufacturing specifications include:

  • Diameter tolerance: ±0.5 mm to ensure proper seating in wellbore perforations 13
  • Density: 1.575-1.625 g/cm³ to achieve neutral buoyancy in fracturing fluids (specific gravity 1.05-1.15) 20
  • Compressive strength: >80 MPa to withstand differential pressures up to 5,000 psi 13
  • Degradation timeline: Complete dissolution within 7-30 days at downhole temperatures (60-120°C) 4

The extrusion process for ball sealer stock involves:

  1. Resin selection: PGA with melt viscosity 200-2,000 Pa·s at 270°C, 120 sec⁻¹ 413
  2. Extrusion molding: Annular die extrusion at 250-270°C with back pressure application (0.5-2.0 MPa) 13
  3. Controlled cooling: Gradual cooling to 180-200°C over 10-30 minutes to minimize residual stress 13
  4. Machining: CNC turning and drilling to final spherical geometry with surface roughness <3.2 μm Ra 13

PGA ball sealers offer advantages over conventional dissolvable alloys (magnesium, aluminum) including lower material costs ($50-100 per ball vs. $200-500), reduced environmental impact, and compatibility with high-salinity brines 4.

Temporary Plugs And Mandrels

PGA tubes serve as biodegradable mandrels for composite liner installation and temporary plugs for well intervention operations 13. Typical dimensions

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
HumacyteVascular graft replacement for patients requiring small-diameter blood vessel substitutes, particularly in cardiovascular and peripheral vascular surgical applications.Tissue-Engineered Vascular Grafts (TEVG)Tubular PGA scaffolds with seam density 50-70 mg/cc enable uniform cell seeding and ECM deposition, achieving burst pressures exceeding 2,000 mmHg and patency rates >80% over 6-month implantation.
Kureha CorporationMulti-stage hydraulic fracturing operations in petroleum wells requiring temporary zonal isolation, particularly in high-temperature downhole environments.PGA Ball Sealers for Hydraulic FracturingExtrusion-molded PGA tubes with melt viscosity 200-2,000 Pa·s at 270°C achieve compressive strength >80 MPa and complete downhole degradation within 7-30 days at 60-120°C, eliminating need for mechanical retrieval.
Kureha CorporationAbsorbable surgical sutures for wound closure in general surgery, orthopedic procedures, and soft tissue repair requiring high initial strength and predictable degradation.High-Strength PGA Monofilament SuturesOptimized melt-spinning process with residual monomer <0.5 wt% produces filaments achieving tensile strength 750-900 MPa and knot strength 600-750 MPa with complete absorption in 90-120 days.
American Cyanamid CompanyOrthopedic fixation devices for fracture repair, ACL reconstruction, and meniscal repair requiring biodegradable implants with gradual load transfer to healing tissue.PGA Prosthetic DevicesSolid PGA constructs provide surgically useful mechanical properties as reinforcing pins, screws, and plates that are absorbed and replaced by living tissue over 4-6 months, eliminating need for removal surgery.
Kureha CorporationFood and beverage packaging applications requiring superior gas barrier properties and heat resistance for hot-filling processes while maintaining transparency and durability.Multilayer PGA Barrier ContainersCo-injection stretch blow molding embeds 10-30 μm PGA intermediate layers between PET layers, achieving oxygen transmission rates <0.05 cc/(m²·day·atm) and hot-fill resistance at 93°C for 20 seconds.
Reference
  • Low-melt-viscosity polyglycolic acid, process for producing the same, and use of the low-melt-viscosity polyglycolic acid
    PatentInactiveEP2189486A1
    View detail
  • Tissue-engineered constructs
    PatentWO2014008239A1
    View detail
  • scaffold
    PatentWO2007132186A2
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png